Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balazs Halmos

The oncologist

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Oncologist|May 27, 2025
Thoracic SMARCA4-deficient undifferentiated tumor: diagnostic characteristics, molecular insights, and treatment approachesJunmin Song, Adam Gersten, Benjamin Herzberg, et al.
The Oncologist|May 4, 2017
DNA Polymerase ɛ Deficiency Leading to an Ultramutator Phenotype: A Novel Clinically Relevant EntityEnrico Castellucci, Tianfang He, D Yitzchak Goldstein, et al.
The Oncologist|July 23, 2025
Datopotamab Deruxtecan-Associated Select Adverse Events: Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and ManagementAaron Lisberg, Laura A Huppert, Balazs Halmos, et al.
The Oncologist|April 28, 2020
INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal MalignanciesKhvaramze Shaverdashvili, Elham Azimi-Nekoo, Perry Cohen, et al.
The Oncologist|August 27, 2015
Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung CancerBalazs Halmos, Nathan A Pennell, Pingfu Fu, et al.
The Oncologist|October 24, 2020
Do Patients Regret Having Received Systemic Treatment for Advanced Non-Small Cell Lung Cancer: A Prospective EvaluationPatricia J Hollen, Richard J Gralla, Ryan D Gentzler, et al.
The Oncologist|July 13, 2024
Calls to action on lung cancer management and researchMay-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.
The Oncologist|July 10, 2024
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumorsDan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Oncologist|May 27, 2025
Thoracic SMARCA4-deficient undifferentiated tumor: diagnostic characteristics, molecular insights, and treatment approachesJunmin Song, Adam Gersten, Benjamin Herzberg, et al.
The Oncologist|May 4, 2017
DNA Polymerase ɛ Deficiency Leading to an Ultramutator Phenotype: A Novel Clinically Relevant EntityEnrico Castellucci, Tianfang He, D Yitzchak Goldstein, et al.
The Oncologist|July 23, 2025
Datopotamab Deruxtecan-Associated Select Adverse Events: Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and ManagementAaron Lisberg, Laura A Huppert, Balazs Halmos, et al.
The Oncologist|April 28, 2020
INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal MalignanciesKhvaramze Shaverdashvili, Elham Azimi-Nekoo, Perry Cohen, et al.
The Oncologist|August 27, 2015
Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung CancerBalazs Halmos, Nathan A Pennell, Pingfu Fu, et al.
The Oncologist|October 24, 2020
Do Patients Regret Having Received Systemic Treatment for Advanced Non-Small Cell Lung Cancer: A Prospective EvaluationPatricia J Hollen, Richard J Gralla, Ryan D Gentzler, et al.
The Oncologist|July 13, 2024
Calls to action on lung cancer management and researchMay-Lucie Meyer, Fred R Hirsch, Paul A Bunn, et al.
The Oncologist|July 10, 2024
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumorsDan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi, et al.
Pageof 1